Date of Publication :5th November 2024

Abstract:
Background: This study was conducted to assess the Efficacy of Biosilicate Glass-ceramic and Fluoride Varnish in the Treatment of Dentin Hypersensitivity.
Material and methods: This study was conducted to assess the effectiveness of Biosilicate Glass Ceramic and Fluoride Varnish in the treatment of dentin hypersensitivity (DH). The study comprised of 50 subjects reporting with dentine hypersensitivity (DH). The subjects had been explained the procedure and were asked to provide consent. The subjects who agreed to provide consent had been included in the study. The subjects belonged to the age group of 20-40 years with the mean age of 27.8 years. The subjects had been divided into 2 groups based on the treatment. Group 1 comprised of 25 subjects whose teeth were treated with Biosilicate Glass Ceramic and group 2 comprised of the remaining 25 subjects whose teeth had been treated with Duraphat Varnish. A visual analogue scale (VAS) was used to assess the level of pain, using volatile and tactile tests. Each product was randomly applied on one tooth per participant once a week for 4 weeks and evaluated every 15 days for 60 days after the last application. Statisti cal analysis was conducted using SPSS software.
Results: In this study, 11 (22%) subjects belonged to the age group of 20-25 years, 32 (64%) subjects belonged to the age group of 26-30 years, 5 (10%) subjects belonged to the age group of 31-35 years and 2 (4%) subjects belonged to the age group of 36-40 years Group 1 comprised of 25 subjects whose teeth were treated with Biosilicate Glass Ceramic while Group 2 comprised of 25 subjec ts who had been treated using Duraphat Varnish. The average Visual Analog Scale (VAS) scores recorded during the preliminary assessment of volatile sensitivity were 6.95±3.25 for the Biosilicate group and 6.74±3.19 for the Duraphat group. By the fourth week, these scores decreased to 0.53±1.1 for Biosilicate and 0.67±1.8 for Duraphat. After a period of 60 days, the volatile sensitivity values were noted as 0.87±1.9 for the Biosilicate group and 1.01±1.3 for the Duraphat group. Initial tactile sensitivity measurements were 1.56±2. 94 for Biosilicate and 1.47±2.58 for Duraphat. At the 60-day follow-up, tactile sensitivity scores were recorded as 0.26±0.68 for Biosilicate and 0.11±0.27 for Duraphat, indicating a statistically significant difference.
Conclusion: The findings of this research demonstrated that both products effectively facilitated a significant decrease in dentin hypersensitivity, yielding comparable outcomes over a 60-day observation period.

Reference :